Skip to main content
Erschienen in: European Journal of Nutrition 2/2019

12.05.2018 | Original Contribution

Estimated daily quercetin intake and association with the prevalence of type 2 diabetes mellitus in Chinese adults

verfasst von: Zhanxin Yao, Yeqing Gu, Qing Zhang, Li Liu, Ge Meng, Hongmei Wu, Yang Xia, Xue Bao, Hongbin Shi, Shaomei Sun, Xing Wang, Ming Zhou, Qiyu Jia, Yuntang Wu, Kun Song, Weina Gao, Changjiang Guo, Kaijun Niu

Erschienen in: European Journal of Nutrition | Ausgabe 2/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Quercetin is one of potential antidiabetic substances because of its powerful antioxidant and anti-inflammatory actions. The purpose of this study is to estimate daily quercetin intake and assess the relationship between dietary quercetin intake and the prevalence of type 2 diabetes mellitus (T2DM) in a Chinese population.

Methods

Dietary intake was investigated by a validated 100-item food frequency questionnaire. Daily intakes of quercetin and nutrients were calculated accordingly. T2DM was diagnosed based on the criteria of the American Diabetes Association. Adjusted logistic regression models were used to analyze the relationship between the quartiles of quercetin intake and the prevalence of T2DM.

Results

The prevalences of T2DM were 8.35% in men and 4.68% in women. The main food sources of quercetin were apple, orange, and green tea. Daily intake of quercetin was 20.9 ± 2.32 mg/day (mean ± SD). After adjusting for potentially confounding factors, the odds ratios (95% CI) for T2DM across the ascending quartiles of quercetin intake were: 1.00 (reference), 0.75 (0.60–0.95), 0.76 (0.59–0.99), and 0.63 (0.51–0.94).

Conclusions

The results of the present study showed that quercetin intake was inversely related to the prevalence of T2DM in the Chinese population, suggesting a protective effect of quercetin in the development of T2DM.
Literatur
1.
Zurück zum Zitat Sheetz MJ, King GL (2002) Molecular understanding of hyperglycemia’s adverse effects for diabetic complications. JAMA 288(20):2579–2588CrossRef Sheetz MJ, King GL (2002) Molecular understanding of hyperglycemia’s adverse effects for diabetic complications. JAMA 288(20):2579–2588CrossRef
8.
Zurück zum Zitat Spranger J, Kroke A, Mohlig M, Hoffmann K, Bergmann MM, Ristow M, Boeing H, Pfeiffer AF (2003) Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. Diabetes 52(3):812–817CrossRef Spranger J, Kroke A, Mohlig M, Hoffmann K, Bergmann MM, Ristow M, Boeing H, Pfeiffer AF (2003) Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. Diabetes 52(3):812–817CrossRef
9.
Zurück zum Zitat Heijnen CG, Haenen GR, Oostveen RM, Stalpers EM, Bast A (2002) Protection of flavonoids against lipid peroxidation: the structure activity relationship revisited. Free Radic Res 36(5):575–581CrossRef Heijnen CG, Haenen GR, Oostveen RM, Stalpers EM, Bast A (2002) Protection of flavonoids against lipid peroxidation: the structure activity relationship revisited. Free Radic Res 36(5):575–581CrossRef
11.
Zurück zum Zitat Su JF, Guo CJ, Wei JY, Yang JJ, Jiang YG, Li YF (2003) Protection against hepatic ischemia-reperfusion injury in rats by oral pretreatment with quercetin. BES 16(1):1–8PubMed Su JF, Guo CJ, Wei JY, Yang JJ, Jiang YG, Li YF (2003) Protection against hepatic ischemia-reperfusion injury in rats by oral pretreatment with quercetin. BES 16(1):1–8PubMed
13.
Zurück zum Zitat Vessal M, Hemmati M, Vasei M (2003) Antidiabetic effects of quercetin in streptozocin-induced diabetic rats. CBP 135c(3):357–364 Vessal M, Hemmati M, Vasei M (2003) Antidiabetic effects of quercetin in streptozocin-induced diabetic rats. CBP 135c(3):357–364
16.
Zurück zum Zitat Knekt P, Kumpulainen J, Jarvinen R, Rissanen H, Heliovaara M, Reunanen A, Hakulinen T, Aromaa A (2002) Flavonoid intake and risk of chronic diseases. Am J Clin Nutr 76(3):560–568CrossRef Knekt P, Kumpulainen J, Jarvinen R, Rissanen H, Heliovaara M, Reunanen A, Hakulinen T, Aromaa A (2002) Flavonoid intake and risk of chronic diseases. Am J Clin Nutr 76(3):560–568CrossRef
17.
Zurück zum Zitat Song Y, Manson JE, Buring JE, Sesso HD, Liu S (2005) Associations of dietary flavonoids with risk of type 2 diabetes, and markers of insulin resistance and systemic inflammation in women: a prospective study and cross-sectional analysis. J Am Coll Nutr 24(5):376–384CrossRef Song Y, Manson JE, Buring JE, Sesso HD, Liu S (2005) Associations of dietary flavonoids with risk of type 2 diabetes, and markers of insulin resistance and systemic inflammation in women: a prospective study and cross-sectional analysis. J Am Coll Nutr 24(5):376–384CrossRef
18.
Zurück zum Zitat Sun Q, Wedick NM, Tworoger SS, Pan A, Townsend MK, Cassidy A, Franke AA, Rimm EB, Hu FB, van Dam RM (2015) Urinary excretion of select dietary polyphenol metabolites is associated with a lower risk of type 2 diabetes in proximate but not remote follow-up in a prospective investigation in 2 cohorts of US women. J Nutr 145(6):1280–1288. https://doi.org/10.3945/jn.114.208736 CrossRefPubMedPubMedCentral Sun Q, Wedick NM, Tworoger SS, Pan A, Townsend MK, Cassidy A, Franke AA, Rimm EB, Hu FB, van Dam RM (2015) Urinary excretion of select dietary polyphenol metabolites is associated with a lower risk of type 2 diabetes in proximate but not remote follow-up in a prospective investigation in 2 cohorts of US women. J Nutr 145(6):1280–1288. https://​doi.​org/​10.​3945/​jn.​114.​208736 CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Gu Y, Li H, Bao X, Zhang Q, Liu L, Meng G, Wu H, Du H, Shi H, Xia Y, Su Q, Fang L, Yu F, Yang H, Yu B, Sun S, Wang X, Zhou M, Jia Q, Guo Q, Chang H, Wang G, Huang G, Song K, Niu K (2017) The relationship between thyroid function and the prevalence of type 2 diabetes mellitus in euthyroid subjects. J Clin Endocrinol Metab 102(2):434–442. https://doi.org/10.1210/jc.2016-2965 CrossRefPubMed Gu Y, Li H, Bao X, Zhang Q, Liu L, Meng G, Wu H, Du H, Shi H, Xia Y, Su Q, Fang L, Yu F, Yang H, Yu B, Sun S, Wang X, Zhou M, Jia Q, Guo Q, Chang H, Wang G, Huang G, Song K, Niu K (2017) The relationship between thyroid function and the prevalence of type 2 diabetes mellitus in euthyroid subjects. J Clin Endocrinol Metab 102(2):434–442. https://​doi.​org/​10.​1210/​jc.​2016-2965 CrossRefPubMed
22.
Zurück zum Zitat Yuexin Y (2009) China food composition. Peking University Medical Press, Beijing Yuexin Y (2009) China food composition. Peking University Medical Press, Beijing
23.
Zurück zum Zitat Guo CXJ, Wei J, Yang J, Wu J (2009) Flavonoid contents of common vegetables in china. Acta Nutrimenta Sinica 3:185–190 Guo CXJ, Wei J, Yang J, Wu J (2009) Flavonoid contents of common vegetables in china. Acta Nutrimenta Sinica 3:185–190
24.
Zurück zum Zitat Guo C, Wei J, Yang J, Wu J (2008) The flavonoid content of common fruits in China. Acta Nutrimenta Sinica 30:130–135 Guo C, Wei J, Yang J, Wu J (2008) The flavonoid content of common fruits in China. Acta Nutrimenta Sinica 30:130–135
25.
Zurück zum Zitat Liu Y, Wei J, Pu L, Wu J, Yang J, Guo C (2010) Effect of different seasons on flavonoids contents of vegetables. Acta Nutrimenta Sinica 32(6):587–591 Liu Y, Wei J, Pu L, Wu J, Yang J, Guo C (2010) Effect of different seasons on flavonoids contents of vegetables. Acta Nutrimenta Sinica 32(6):587–591
29.
Zurück zum Zitat Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC Jr, International Diabetes Federation Task Force on E, Prevention, National Heart L, Blood I, American Heart A, World Heart F, International Atherosclerosis S, International Association for the Study of O (2009) Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120(16):1640–1645. https://doi.org/10.1161/CIRCULATIONAHA.109.192644 CrossRefPubMed Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC Jr, International Diabetes Federation Task Force on E, Prevention, National Heart L, Blood I, American Heart A, World Heart F, International Atherosclerosis S, International Association for the Study of O (2009) Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120(16):1640–1645. https://​doi.​org/​10.​1161/​CIRCULATIONAHA.​109.​192644 CrossRefPubMed
30.
Zurück zum Zitat Zamora-Ros R, Knaze V, Lujan-Barroso L, Slimani N, Romieu I, Fedirko V, de Magistris MS, Ericson U, Amiano P, Trichopoulou A, Dilis V, Naska A, Engeset D, Skeie G, Cassidy A, Overvad K, Peeters PH, Huerta JM, Sanchez MJ, Quiros JR, Sacerdote C, Grioni S, Tumino R, Johansson G, Johansson I, Drake I, Crowe FL, Barricarte A, Kaaks R, Teucher B, Bueno-de-Mesquita HB, van Rossum CT, Norat T, Romaguera D, Vergnaud AC, Tjonneland A, Halkjaer J, Clavel-Chapelon F, Boutron-Ruault MC, Touillaud M, Salvini S, Khaw KT, Wareham N, Boeing H, Forster J, Riboli E, Gonzalez CA (2011) Estimated dietary intakes of flavonols, flavanones and flavones in the European Prospective Investigation into Cancer and Nutrition (EPIC) 24 hour dietary recall cohort. Br J Nutr 106(12):1915–1925. https://doi.org/10.1017/s000711451100239x CrossRefPubMed Zamora-Ros R, Knaze V, Lujan-Barroso L, Slimani N, Romieu I, Fedirko V, de Magistris MS, Ericson U, Amiano P, Trichopoulou A, Dilis V, Naska A, Engeset D, Skeie G, Cassidy A, Overvad K, Peeters PH, Huerta JM, Sanchez MJ, Quiros JR, Sacerdote C, Grioni S, Tumino R, Johansson G, Johansson I, Drake I, Crowe FL, Barricarte A, Kaaks R, Teucher B, Bueno-de-Mesquita HB, van Rossum CT, Norat T, Romaguera D, Vergnaud AC, Tjonneland A, Halkjaer J, Clavel-Chapelon F, Boutron-Ruault MC, Touillaud M, Salvini S, Khaw KT, Wareham N, Boeing H, Forster J, Riboli E, Gonzalez CA (2011) Estimated dietary intakes of flavonols, flavanones and flavones in the European Prospective Investigation into Cancer and Nutrition (EPIC) 24 hour dietary recall cohort. Br J Nutr 106(12):1915–1925. https://​doi.​org/​10.​1017/​s000711451100239​x CrossRefPubMed
31.
Zurück zum Zitat Ilow R, Regulska-Ilow B, Rozanska D, Misiewicz D, Grajeta H, Kowalisko A, Biernat J (2012) Assessment of dietary flavonoid intake among 50-year-old inhabitants of Wroclaw in 2008. Advances in clinical and experimental medicine: official organ. Wroclaw Med Univ 21(3):353–362 Ilow R, Regulska-Ilow B, Rozanska D, Misiewicz D, Grajeta H, Kowalisko A, Biernat J (2012) Assessment of dietary flavonoid intake among 50-year-old inhabitants of Wroclaw in 2008. Advances in clinical and experimental medicine: official organ. Wroclaw Med Univ 21(3):353–362
32.
Zurück zum Zitat Hertog MG, Kromhout D, Aravanis C, Blackburn H, Buzina R, Fidanza F, Giampaoli S, Jansen A, Menotti A, Nedeljkovic S et al (1995) Flavonoid intake and long-term risk of coronary heart disease and cancer in the seven countries study. Arch Intern Med 155(4):381–386CrossRef Hertog MG, Kromhout D, Aravanis C, Blackburn H, Buzina R, Fidanza F, Giampaoli S, Jansen A, Menotti A, Nedeljkovic S et al (1995) Flavonoid intake and long-term risk of coronary heart disease and cancer in the seven countries study. Arch Intern Med 155(4):381–386CrossRef
33.
Zurück zum Zitat Foster-Powell K, Miller JB (1995) International tables of glycemic index. Am J Clin Nutr 62(4):871s–890sCrossRef Foster-Powell K, Miller JB (1995) International tables of glycemic index. Am J Clin Nutr 62(4):871s–890sCrossRef
34.
Zurück zum Zitat Arai Y, Watanabe S, Kimira M, Shimoi K, Mochizuki R, Kinae N (2000) Dietary intakes of flavonols, flavones and isoflavones by Japanese women and the inverse correlation between quercetin intake and plasma LDL cholesterol concentration. J Nutr 130(9):2243–2250CrossRef Arai Y, Watanabe S, Kimira M, Shimoi K, Mochizuki R, Kinae N (2000) Dietary intakes of flavonols, flavones and isoflavones by Japanese women and the inverse correlation between quercetin intake and plasma LDL cholesterol concentration. J Nutr 130(9):2243–2250CrossRef
36.
Zurück zum Zitat Gao W, Wei J, Pu L, Liu Y, Guo C, Zhao L, Cai Y, Wu C (2014) Comparison of dietary intakes of myricetin, quercetin, kaempferol, apigenin and luteolin from vegetables and fruits in Chinese adults from four different regions. Acta Nutrimenta Sinica 36(6):559–564 Gao W, Wei J, Pu L, Liu Y, Guo C, Zhao L, Cai Y, Wu C (2014) Comparison of dietary intakes of myricetin, quercetin, kaempferol, apigenin and luteolin from vegetables and fruits in Chinese adults from four different regions. Acta Nutrimenta Sinica 36(6):559–564
37.
Zurück zum Zitat Panda S, Kar A (2007) Antidiabetic and antioxidative effects of Annona squamosa leaves are possibly mediated through quercetin-3-O-glucoside. BioFactors 31(3–4):201–210CrossRef Panda S, Kar A (2007) Antidiabetic and antioxidative effects of Annona squamosa leaves are possibly mediated through quercetin-3-O-glucoside. BioFactors 31(3–4):201–210CrossRef
49.
50.
Zurück zum Zitat Chen HF, Ho CA, Li CY (2006) Age and sex may significantly interact with diabetes on the risks of lower-extremity amputation and peripheral revascularization procedures: evidence from a cohort of a half-million diabetic patients. Diabetes Care 29(11):2409–2414. https://doi.org/10.2337/dc06-1343 CrossRefPubMed Chen HF, Ho CA, Li CY (2006) Age and sex may significantly interact with diabetes on the risks of lower-extremity amputation and peripheral revascularization procedures: evidence from a cohort of a half-million diabetic patients. Diabetes Care 29(11):2409–2414. https://​doi.​org/​10.​2337/​dc06-1343 CrossRefPubMed
54.
57.
Zurück zum Zitat Ruhe RC, McDonald RB (2001) Use of antioxidant nutrients in the prevention and treatment of type 2 diabetes. J Am Coll Nutr 20(5 Suppl):363S–369S (discussion 381S–383S) Ruhe RC, McDonald RB (2001) Use of antioxidant nutrients in the prevention and treatment of type 2 diabetes. J Am Coll Nutr 20(5 Suppl):363S–369S (discussion 381S–383S)
Metadaten
Titel
Estimated daily quercetin intake and association with the prevalence of type 2 diabetes mellitus in Chinese adults
verfasst von
Zhanxin Yao
Yeqing Gu
Qing Zhang
Li Liu
Ge Meng
Hongmei Wu
Yang Xia
Xue Bao
Hongbin Shi
Shaomei Sun
Xing Wang
Ming Zhou
Qiyu Jia
Yuntang Wu
Kun Song
Weina Gao
Changjiang Guo
Kaijun Niu
Publikationsdatum
12.05.2018
Verlag
Springer Berlin Heidelberg
Erschienen in
European Journal of Nutrition / Ausgabe 2/2019
Print ISSN: 1436-6207
Elektronische ISSN: 1436-6215
DOI
https://doi.org/10.1007/s00394-018-1713-2

Weitere Artikel der Ausgabe 2/2019

European Journal of Nutrition 2/2019 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Battle of Experts: Sport vs. Spritze bei Adipositas und Typ-2-Diabetes

11.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Im Battle of Experts traten zwei Experten auf dem Diabeteskongress gegeneinander an: Die eine vertrat die Auffassung „Sport statt Spritze“ bei Adipositas und Typ-2-Diabetes, der andere forderte „Spritze statt Sport!“ Am Ende waren sie sich aber einig: Die Kombination aus beidem erzielt die besten Ergebnisse.

Vorsicht, erhöhte Blutungsgefahr nach PCI!

10.05.2024 Koronare Herzerkrankung Nachrichten

Nach PCI besteht ein erhöhtes Blutungsrisiko, wenn die Behandelten eine verminderte linksventrikuläre Ejektionsfraktion aufweisen. Das Risiko ist umso höher, je stärker die Pumpfunktion eingeschränkt ist.

Triglyzeridsenker schützt nicht nur Hochrisikopatienten

10.05.2024 Hypercholesterinämie Nachrichten

Patienten mit Arteriosklerose-bedingten kardiovaskulären Erkrankungen, die trotz Statineinnahme zu hohe Triglyzeridspiegel haben, profitieren von einer Behandlung mit Icosapent-Ethyl, und zwar unabhängig vom individuellen Risikoprofil.

Gibt es eine Wende bei den bioresorbierbaren Gefäßstützen?

In den USA ist erstmals eine bioresorbierbare Gefäßstütze – auch Scaffold genannt – zur Rekanalisation infrapoplitealer Arterien bei schwerer PAVK zugelassen worden. Das markiert einen Wendepunkt in der Geschichte dieser speziellen Gefäßstützen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.